Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
04/1999
04/29/1999WO1999020261A2 Use of antigunal agents for the topial treatment of fungus-induced mucositis
04/29/1999WO1999020253A1 Encapsulation method
04/29/1999WO1999020122A1 Increasing the digestibility of food proteins by thioredoxin reduction
04/29/1999WO1999006069A9 Herpes virus replication defective mutants
04/29/1999WO1999006066A3 Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions
04/29/1999WO1999001473A3 Anti-bacterial methods and materials
04/29/1999WO1998058669A3 Cd154 blockade therapy for pancreatic islet tissue transplantation
04/29/1999DE19746868A1 Use of tumour necrosis factor antagonists
04/29/1999CA2307639A1 Tumour vaccine
04/29/1999CA2307331A1 Passive immunization against clostridium difficile disease
04/29/1999CA2307012A1 Xenogeneic cholesteryl ester transfer protein (cetp) for modulation of cetp activity
04/29/1999CA2306995A1 Compositions and methods for systemic delivery of oral vaccines and therapeutic agents
04/29/1999CA2306799A1 Novel modified nucleic acid sequences and methods for increasing mrna levels and protein expression in cell systems
04/29/1999CA2306796A1 Novel modified msp-1 nucleic acid sequences and methods for increasing mrna levels and protein expression in cell systems
04/29/1999CA2306642A1 Neospora vaccines
04/29/1999CA2305891A1 New species of lactic acid bacterium
04/29/1999CA2305385A1 Human toll homologues
04/28/1999EP0911633A1 A method of identifying agonists and antagonists for tumor necrosis related receptors TR1, TR3 and TR5
04/28/1999EP0911410A2 Era polynucleotides and polypeptides from Streptococcus pneumoniae belonging to the GTPase family
04/28/1999EP0911409A2 Deformylase
04/28/1999EP0911407A1 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratC
04/28/1999EP0911406A2 Histidine kinase from Staphylococcus aureus
04/28/1999EP0911405A2 Gapdh
04/28/1999EP0911403A2 MurB gene from Streptococcus pneumoniae
04/28/1999EP0911402A2 PyrR homolog from Staphylococcus aureus
04/28/1999EP0911399A2 A kringle-related clone, HTHBZ47
04/28/1999EP0911398A2 Phosphorylation epitopes of Tau protein for the diagnosis and treatment of Alzheimer's disease
04/28/1999EP0911391A2 A clone HWHHJ20
04/28/1999EP0911390A2 Protein kinases as tools for the diagnosis and treatment of Alzheimer's disease
04/28/1999EP0911342A1 Novel protein and process for producing the same
04/28/1999EP0911036A2 Dual carrier immunogenic construct
04/28/1999EP0910669A1 Isolated nucleic acid molecules which are members of the mage-b family and uses thereof
04/28/1999EP0910659A2 Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections
04/28/1999EP0910657A1 Canine herpesvirus based recombinant live vaccine, in particular against canine distemper, rabies or the parainfluenza 2 virus
04/28/1999EP0910656A1 Virus-like particles useful as a vector for delivering nucleic acid
04/28/1999EP0910655A1 Vaccines for treatment of lymphoma and leukemia
04/28/1999EP0910650A1 Transgenic plants expressing rabies glycoprotein g, and glycoproteins thus obtained
04/28/1999EP0910646A1 Brain glycogen phosphorylase cancer antigen
04/28/1999EP0910639A1 HUMAN cAMP-DEPENDENT PROTEIN KINASE INHIBITOR HOMOLOG
04/28/1999EP0910638A2 Polynucleotide encoding secreted proteins
04/28/1999EP0910632A2 Presentation of antigen, introduced into the cells by stimulation of macropinocytosis
04/28/1999EP0910626A1 Conditional immortalisation process for human tumour cells for producing a vaccine
04/28/1999EP0910571A2 Novel antiangiogenic peptides, polypeptides encoding same and methods for inhibiting angiogenesis
04/28/1999EP0910413A2 TREATMENT OF ASTHMA WITH TNFR-Ig
04/28/1999EP0910408A1 DELIVERY SYSTEM USING mAb 3E10 AND MUTANTS AND/OR FUNCTIONAL FRAGMENTS THEREOF
04/28/1999EP0910407A1 Method and composition for reconforming multi-epitopic antigens to initiate an immune response
04/28/1999EP0910406A1 Recombinant canine herpesviruses
04/28/1999EP0910405A2 Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection
04/28/1999EP0910404A1 A vaccine composition comprising helicobacter pylori flagellin polypeptide
04/28/1999EP0910403A1 Stationary phase, stress response sigma factor from mycobacterium tuberculosis, and regulation thereof
04/28/1999EP0910376A2 Use of clotrimazole and related compounds in the treatment of diarrhea
04/28/1999EP0910340A1 Functionalized nanotubes
04/28/1999EP0681479B1 Immunotherapeutic composition
04/28/1999EP0658119B1 New hiv-1 isolates of a subtype and its differential diagnosis, vaccine against hiv-1 infection of this subtype and process for preparing and using the hiv-1 isolate
04/28/1999EP0592480B1 Use of papillomavirus L2 protein for therapeutic treatment of papillomavirus tumours or lesions
04/28/1999EP0585364B1 Ctaa 81av78, the antigen recognized by human monoclonal antibody 81av78
04/28/1999CN1215407A Human antibodies that bind huma TNF 'alpha'
04/28/1999CN1215404A Non-dendritic backbone piptide carrier
04/28/1999CN1215340A Composition comprising interleukin-1 inhibitor and controlled release polymer
04/28/1999CN1215337A Vaccine comprising a polysaccharide antigen-carrier protein conjugate and free carrier protein
04/28/1999CN1214938A Frozen dried heptitis A toxicity-reduced bio-vaccine and protective agent thereof
04/28/1999CA2248274A1 Novel dbpa
04/28/1999CA2248270A1 Novel dbpb
04/27/1999US5897867 Efficacious vaccines against Bordetella pertussis comprising a combination of individually purified pertussis antigens
04/27/1999US5897865 Turmeric for treating skin disorders
04/27/1999US5897863 LHRH hormones
04/27/1999US5897862 Immuno-stimulatory monoclonal antibodies
04/27/1999US5897852 Container having vaccine components present in freeze dried bodies, at least one having single vaccine component, and at least one being lyosphere
04/27/1999CA2248119A1 Novel apt
04/27/1999CA2248116A1 Novel muty
04/27/1999CA2243874A1 Antibody recognizing body fluid cell surface antigen
04/27/1999CA2107329C Anti-human immunodeficiency virus recombinant antibodies
04/27/1999CA2073168C Biomass for producing virus/virus antigen
04/27/1999CA2064585C Inhibition of tumor growth by blockade of the protein c system
04/24/1999CA2248170A1 A clone hwhhj20
04/23/1999CA2245997A1 Novel compounds
04/23/1999CA2239255A1 Cdna clone hneaa81 that encodes a human 7-transmembrane receptor
04/22/1999WO1999019732A1 Methods and compositions for detecting hepatitis e virus
04/22/1999WO1999019487A1 Mammoglobin homolog
04/22/1999WO1999019486A1 Cell division regulators
04/22/1999WO1999019484A1 T cell receptor-associated molecules (trams) and methods of use therefor
04/22/1999WO1999019483A1 Human progesterone receptor complex p23-like protein
04/22/1999WO1999019480A2 Human receptor proteins; related reagents and methods
04/22/1999WO1999019479A1 Murine model for human carcinoma
04/22/1999WO1999019478A1 Agonist and antagonist peptides of carcinoembryonic antigen (cea)
04/22/1999WO1999019477A1 Cadherin derived growth factor and the application thereof
04/22/1999WO1999019476A2 NON-MAMMALIAN MESODERM INDUCTION EARLY RESPONSE (nm-MIER) GENE FAMILY
04/22/1999WO1999019473A1 Transgenic animal models for cardiac hypertrophy and uses thereof
04/22/1999WO1999019471A1 Models and treatments for cardiac hypertrophy in relation with nf-at3 function
04/22/1999WO1999019359A1 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle
04/22/1999WO1999019357A2 Cell regulatory genes, encoded products, and uses related thereto
04/22/1999WO1999019356A1 Trivalent thrombin inhibitor
04/22/1999WO1999019354A1 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof
04/22/1999WO1999019351A1 Novel npy family member
04/22/1999WO1999019349A1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
04/22/1999WO1999019343A1 Viral clearance process
04/22/1999WO1999019339A1 53 human secreted proteins
04/22/1999WO1999018997A1 Potentiator for antibody against lymphoid tumor
04/22/1999WO1999018996A1 Enterococcus antigens and vaccines
04/22/1999WO1999018995A1 Immunogenic peptides from the hpv e7 protein
1 ... 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 ... 1823